The behaviour of blood lymphocyte subsets in patients treated with immunochemotherapy for metastatic melanoma.
Francavilla
V
V
Clinical Pathology Laboratory, Regina Elena National Institute of Cancer, Rome, Italy.
Arista
M C
MC
Carpano
S
S
Valente
F
F
Vercillo
M
M
De Franceschi
L
L
Conti
L
L
Lopez
M
M
D015703:Antigens, CD / Q000032:analysis; D003606:Dacarbazine / Q000627:therapeutic use; D005260:Female; D005434:Flow Cytometry; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D016130:Immunophenotyping; D007376:Interleukin-2 / Q000627:therapeutic use; D016131:Lymphocyte Subsets / Q000166:cytology; D008297:Male; D008545:Melanoma / Q000276:immunology* / Q000556:secondary / Q000628:therapy; D008875:Middle Aged
D015703:Antigens, CD; D006684:HLA-DR Antigens; D007376:Interleukin-2; D003606:Dacarbazine